Rituximab plus Short-Duration Chemotherapy Followed by Yttrium-90 Ibritumomab Tiuxetan as First-Line Treatment for Patients with Follicular Non-Hodgkin Lymphoma: A Phase II Trial of the Sarah Cannon Oncology Research Consortium

✍ Scribed by Hainsworth, John D.; Spigel, David R.; Markus, Tiffanie M.; Shipley, Dianna; Thompson, Dana; Rotman, Richard; Dannaher, Charles; Greco, F. Anthony

• Book ID: 119936110
• Publisher: CIG Media Group, LP.
• Year: 2009
• Tongue: English
• Weight: 121 KB
• Volume: 9
• Category: Article
• ISSN: 1557-9190
• DOI: 10.3816/clm.2009.n.044